Representative Work

David Davachi

Results

All Representative Work

Representative Work

NOVA Chemicals Corporation in its pricing of a private offering of US$400 million of senior unsecured notes

On November 18, 2024, NOVA Chemical Corporation (NOVA) announced the pricing of a private offering of US$400 million of senior unsecured notes. These notes are structured as 7-year non-call 3 years and an interest rate of 7% per annum. TD Securities (USA) LLC acted as lead bookrunner, and RBC...

Lead Office: Toronto Date Announced: Nov 18, 2024 Value: US$400 million

Read more
Representative Work

Chartwell in the establishment of its $250-million at-the-market equity distribution program

On November 14, 2024, Chartwell Retirement Residences filed a prospectus supplement to establish an at-the-market equity distribution program (the ATM program). The ATM program allows Chartwell to issue trust units up to an aggregate sale price of $250 million from treasury to the public from time...

Lead Office: Toronto Date Announced: Nov 14, 2024 Value: $250 million

Read more
Representative Work

Spire Global in its agreement to sell its maritime business for approximately US$241 million

On November 13, 2024, Spire Global announced its agreement to sell its maritime business for approximately US$241 million to Kpler. Spire Global intends to use the proceeds of the sale to retire all outstanding debt and invest in near-term growth opportunities. The transaction consists of a...

Lead Office: Toronto Date Announced: Nov 12, 2024 Value: US$241 million

Read more
Representative Work

Chartwell in its $150-million debentures offering

On October 28, 2024, Chartwell Retirement Residences (Chartwell) closed its previously announced issuance of $150 million of 4.400% Series D senior unsecured debentures. The offering was completed on an agency basis through a syndicate of investment dealers led by TD Securities, BMO Capital...

Lead Office: Toronto Date Closed: October 28, 2024 Value: $150 million

Read more
Representative Work

ParaPRO LLC in its US$89.5-million asset sale to Cipher Pharmaceuticals

On July 29, 2024, Cipher Pharmaceuticals Inc. announced the signing of a definitive asset purchase agreement with ParaPRO LLC (ParaPRO) and the closing of the acquisition of the global product rights for Natroba™ (Spinosad), as well as the commercial sales team in the United States for total...

Lead Office: Toronto Date Announced: Jul 29, 2024 Value: US$ 89.5 million

Read more
Representative Work

Chartwell in its $345 million trust unit offering

On June 27, 2024, Chartwell Retirement Residences (Chartwell) announced the closing of its previously announced public offering of 28,290,000 trust units at a price of $12.20 per unit for total gross proceeds of approximately $345 million. The financing was completed on a bought deal basis through...

Lead Office: Toronto Date Announced: Jun 27, 2024 Value: $345 million

Read more
Representative Work

Emera Inc. in the sale of its interest in the Labrador Island Link

Osler advised Emera Inc. in the sale of its minority equity interest in the Labrador Island Link, a critical energy transmission asset in Newfoundland and Labrador, to Kohlberg Kravis Roberts & Co. for a total transaction value of $1.19 billion. The transaction value was made up of $957...

Lead Office: Toronto Date Announced: Jun 4, 2024 Value: $1.19 billion

Read more
Representative Work

Trilogy in its take-private of Indigo Books & Music

On April 2, 2024, Indigo Books & Music Inc. announced that, based on the unanimous recommendation of an independent committee of its board of directors, it has entered into an arrangement agreement with Trilogy Investments L.P. and Trilogy Retail Holdings Inc. (personal holding companies of...

Lead Office: Toronto Date Closed: -- Value: -

Read more
Representative Work

Fusion Pharmaceuticals in its acquisition by AstraZeneca

On March 19, 2024, Fusion Pharmaceuticals announced that it entered into a definitive agreement to be acquired by AstraZeneca for a transaction value of approximately US$2.4 billion. Through this acquisition, AstraZeneca is taking a significant leap towards its goal of revolutionizing cancer...

Lead Office: Toronto Date Closed: -- Value: US$2.4 billion

Read more
Representative Work

Xos in its business combination with ElectraMeccanica

On January 11, 2024, Xos Inc. announced that it had entered into an agreement with ElectraMeccanica pursuant to which Xos will acquire all of the issued and outstanding common shares of ElectracMeccanica in an all-stock transaction. The transaction represents a unique opportunity for Xos to...

Lead Office: Toronto Date Closed: March 11, 2024 Value: -

Read more